WO2007103711A3 - Polymorphic forms of rimonabant - Google Patents
Polymorphic forms of rimonabant Download PDFInfo
- Publication number
- WO2007103711A3 WO2007103711A3 PCT/US2007/063042 US2007063042W WO2007103711A3 WO 2007103711 A3 WO2007103711 A3 WO 2007103711A3 US 2007063042 W US2007063042 W US 2007063042W WO 2007103711 A3 WO2007103711 A3 WO 2007103711A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rimonabant
- polymorphic forms
- amorphous
- pharmaceutically acceptable
- acceptable carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Polymorphic crystalline Forms III, IV, V, and VI of rimonabant, amorphous rimonabant, and amorphous rimonabant in an intimate dispersion with a pharmaceutically acceptable carrier.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN358CH2006 | 2006-03-01 | ||
| IN358/CHE/2006 | 2006-03-01 | ||
| IN611/CHE/2006 | 2006-04-04 | ||
| IN611CH2006 | 2006-04-04 | ||
| US80567906P | 2006-06-23 | 2006-06-23 | |
| US60/805,679 | 2006-06-23 | ||
| US80778506P | 2006-07-19 | 2006-07-19 | |
| US60/807,785 | 2006-07-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007103711A2 WO2007103711A2 (en) | 2007-09-13 |
| WO2007103711A3 true WO2007103711A3 (en) | 2009-04-02 |
Family
ID=38475673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2007/063042 Ceased WO2007103711A2 (en) | 2006-03-01 | 2007-03-01 | Polymorphic forms of rimonabant |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2007103711A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008026219A2 (en) * | 2006-09-01 | 2008-03-06 | Hetero Drugs Limited | Novel polymorphs of rimonabant |
| WO2008056377A2 (en) * | 2006-11-06 | 2008-05-15 | Cadila Healthcare Limited | Polymorphic forms of rimonabant |
| CZ300115B6 (en) * | 2006-12-01 | 2009-02-11 | Zentiva, A. S. | Process for preparing N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (rimonabant) |
| WO2008064615A2 (en) * | 2006-12-01 | 2008-06-05 | Zentiva, A.S. | Crystalline and amorphous forms of rimonabant and processes for obtaining them |
| US20080182877A1 (en) * | 2007-01-05 | 2008-07-31 | Westheim Raymond J H | Rimonabant forms and methods of making the same |
| WO2008088900A2 (en) * | 2007-01-18 | 2008-07-24 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rimonabant base and processes for preparation thereof |
| FR2913018A1 (en) * | 2007-02-23 | 2008-08-29 | Sanofi Aventis Sa | New pyrazol-3-carboxamide derivative in amorphous form comprising surinabant and rimonabant form, useful for preparing amorphous solid solution |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284277B1 (en) * | 1995-11-03 | 2001-09-04 | Sanofi-Synthelabo | Stable freeze-dried pharmaceutical formulation |
| US20050202092A1 (en) * | 2002-07-18 | 2005-09-15 | Skantze Tommy U. | Process for the preparation of crystalline nano-particle dispersions |
| WO2006087732A1 (en) * | 2005-01-06 | 2006-08-24 | Cadila Healthcare Limited | An amorphous and three crystalline forms of rimonabant hydrochloride |
| US20080070949A1 (en) * | 2006-09-19 | 2008-03-20 | Cipla Limited | Polymorphs of rimonabant |
-
2007
- 2007-03-01 WO PCT/US2007/063042 patent/WO2007103711A2/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284277B1 (en) * | 1995-11-03 | 2001-09-04 | Sanofi-Synthelabo | Stable freeze-dried pharmaceutical formulation |
| US20050202092A1 (en) * | 2002-07-18 | 2005-09-15 | Skantze Tommy U. | Process for the preparation of crystalline nano-particle dispersions |
| WO2006087732A1 (en) * | 2005-01-06 | 2006-08-24 | Cadila Healthcare Limited | An amorphous and three crystalline forms of rimonabant hydrochloride |
| US20080070949A1 (en) * | 2006-09-19 | 2008-03-20 | Cipla Limited | Polymorphs of rimonabant |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007103711A2 (en) | 2007-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007103711A3 (en) | Polymorphic forms of rimonabant | |
| EP2068389B8 (en) | Method for producing separator for fuel cell, separator for fuel cell, and fuel cell | |
| EP1999811B8 (en) | Fuel cells | |
| EP2296185A4 (en) | Substrate for thin-film photoelectric conversion device, thin-film photoelectric conversion including the same, and method for producing substrate for thin-film photoelectric conversion device | |
| GB2411494B (en) | Protocol stack with modification facility | |
| EP2010623B8 (en) | Rheology enhancers | |
| EP2279575A4 (en) | A method for link adaptation with a signal quality margin based on the bandwidth | |
| WO2007148102A3 (en) | Crystalline duloxetine hydrochloride | |
| AU2005234596A8 (en) | Piperazinylpiperidine derivatives as chemokine receptor antagonists | |
| WO2005086156A8 (en) | Arrangement for adaptive bit recovery | |
| EP2093779A4 (en) | Electricity storage device, use thereof, and production method thereof | |
| EP2182794A4 (en) | Cubicle, arrangement in a cubicle and a method for mounting said arrangement | |
| WO2010004386A3 (en) | Amorphous bupropion hydrobromide and preparation thereof | |
| AU2006900362A0 (en) | Quick - hitches: hole diameter adjustment | |
| HK1101688A (en) | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines | |
| HK1137447A (en) | Sub-type selective azabicycloalkane derivatives | |
| HK1132261A (en) | Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride | |
| HK1115063A (en) | Oligodendrocyte precursor cell proliferation regulated by prolactin | |
| AU2004905450A0 (en) | Aminoalcohol Derivatives | |
| AU2004902660A0 (en) | Aminoalcohol Derivatives | |
| AU2004904372A0 (en) | Drill with Two chuck Assemblage | |
| AU2004900106A0 (en) | Reducing fungal growth | |
| AU2006905932A0 (en) | Earsafe, Sun Protectors | |
| AU2004907261A0 (en) | Refridgerated dispenser with timing device, for feeding animals | |
| HK1135699A (en) | New crystalline forms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07757692 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07757692 Country of ref document: EP Kind code of ref document: A2 |